Veterinary Innovation
Default header image

Veterinary Innovation

The Animal Health Partners Research Chair in Veterinary Medical Innovation

Partnership Launch

The Animal Health Partners Research Chair in Veterinary Medical Innovation is a unique and exciting partnership between the Ontario Veterinary College (OVC) at the University of Guelph and the Animal Health Partners (AHP), a veterinary emergency and specialty hospital in Toronto, Ontario. This partnership aims to facilitate a One Health approach to advancing medical diagnoses and therapies in companion animal health and translate this knowledge to accelerate human medical discoveries. In creating this collaborative approach, the AHP Research Chair in Veterinary Medical Innovation expands how the human and veterinary medical communities work together and will create a framework for discovery.

The Research Chair is an OVC faculty member who will act to facilitate and coordinate a range of research activities between partners within the OVC and AHP. The Chair will organize and catalyze the sharing of clinical case material, expertise and specialized equipment, and generate new opportunities for ground-breaking and novel approaches to comparative medical research and training. This work has been made possible by a generous contribution by Animal Health Partners.

Dr. Michelle Oblak

About Dr. Michelle Oblak:

Leading the unique and exciting partnership between the OVC and AHP is Dr. Michelle Oblak. Dr. Oblak is a graduate of the OVC where she also completed a rotating internship and combined Residency/ Doctor of Veterinary Science (DVSc) in Small Animal Surgery. She served as a Postdoctoral Fellow at the University of Florida where she received designation as an ACVS Fellow, Surgical Oncology. Dr. Oblak is currently an Associate Professor of Soft Tissue and Oncologic Surgery in the Department of Clinical Studies, Ontario Veterinary College.

Dr. Oblak is an active and noted researcher with a focus on translational research and has several collaborations considering dogs as a naturally occurring disease model for cancer in humans. Her comparative oncology program at the OVC involves research on osteosarcoma and innovative methods for staging and treatment of dogs with cancer including sentinel lymph node mapping, image guided therapeutics, and 3D printing and rapid prototyping for surgical planning and reconstruction. She is an assistant co-director of the University of Guelph Institute for Comparative Cancer Investigation (ICCI), and an active member of the Dog Osteosarcoma Group: Biomarkers of Neoplasia (DOG BONe) and Rapid prototyping of patient-specific implants for dogs (RaPPID) working group.